- About
- Home
- Introduction
- Statistics
- Programs
- Dignet
- Gene
- GenePair
- BioSummarAI
- Help & Docs
- Documents
- Help
- FAQs
- Links
- Acknowledge
- Disclaimer
- Contact Us
Gene Information
Gene symbol: PASD1
Gene name:
Related Genes
| # | Gene Symbol | Number of hits |
| 1 | BCL6 | 1 hits |
| 2 | CD4 | 1 hits |
| 3 | CD8A | 1 hits |
| 4 | CSAG1 | 1 hits |
| 5 | CTAGE1 | 1 hits |
| 6 | DDX43 | 1 hits |
| 7 | DDX53 | 1 hits |
| 8 | DLX2 | 1 hits |
| 9 | JARID1B | 1 hits |
| 10 | MME | 1 hits |
| 11 | MUM1 | 1 hits |
| 12 | PRAME | 1 hits |
| 13 | SPA17 | 1 hits |
Related Sentences
| # | PMID | Sentence |
| 1 | 15162151 | Here we report that the OX-TES-1 SEREX antigen, which showed immunological reactivity with serum from four out of 10 diffuse large B-cell lymphoma (DLBCL) patients, is encoded by a novel gene, PAS domain containing 1 (PASD1). |
| 2 | 15162151 | Immunophenotyping studies of de novo DLBCL patients' tumours with antibodies to CD10, BCL-6 and MUM1 indicated that two patients mounting an immune response to PASD1 were of a poor prognosis non-germinal centre subtype. |
| 3 | 15162151 | Here we report that the OX-TES-1 SEREX antigen, which showed immunological reactivity with serum from four out of 10 diffuse large B-cell lymphoma (DLBCL) patients, is encoded by a novel gene, PAS domain containing 1 (PASD1). |
| 4 | 15162151 | Immunophenotyping studies of de novo DLBCL patients' tumours with antibodies to CD10, BCL-6 and MUM1 indicated that two patients mounting an immune response to PASD1 were of a poor prognosis non-germinal centre subtype. |
| 5 | 20726502 | The broadest mRNA expression profiles were observed for the following eight CT genes: Sp17 (25/25), PRAME (25/25), CSAGE (24/25), PASD1 (22/25), CAGE/DDX53 (19/25), CTAGE1 (19/25), HAGE/DDX43 (16/25) and PLU-1/JARID1B (15/25). |
| 6 | 20851862 | CD4-positive T-helper cell responses to the PASD1 protein in patients with diffuse large B-cell lymphoma. |
| 7 | 23882161 | An analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide. |